Aetna modified CPB 0563 covering retinopathy telescreening systems, effective December 4, 2025. Here's what changes for billing teams.
Aetna, a CVS Health company, updated its retinopathy telescreening coverage policy under CPB 0563 in the Aetna system. The policy governs CPT codes 92227, 92228, and 92229 for retinal imaging, plus HCPCS code S3000 for bilateral diabetic retinal exams. The update draws a sharper line between covered screening indications and experimental uses — and if your charge capture hasn't caught up, claim denials are coming.
Quick-Reference Table
| Field | Detail |
|---|---|
| Payer | Aetna |
| Policy | Retinopathy Telescreening Systems |
| Policy Code | CPB 0563 |
| Change Type | Modified |
| Effective Date | December 4, 2025 |
| Impact Level | Medium-High |
| Specialties Affected | Ophthalmology, Optometry, Endocrinology, Neonatology, Primary Care, Retinal Imaging Centers |
| Key Action | Audit all claims billed under 92229 for retinopathy of prematurity and stop billing telescreening for disease progression monitoring in already-diagnosed diabetic retinopathy patients. |
Aetna Retinopathy Telescreening Coverage Criteria and Medical Necessity Requirements 2025
Aetna's coverage policy under CPB 0563 covers retinopathy telescreening systems as medically necessary in two specific screening scenarios. The first is diabetic retinopathy screening. The second is retinopathy of prematurity (ROP) screening.
The critical word here is "screening." Aetna covers these systems as an alternative to in-person evaluation by an ophthalmologist or optometrist — not as a replacement for ongoing diagnostic work. If a patient already has a diabetic retinopathy diagnosis and your clinician is using telescreening to track disease progression, that's not covered. Full stop.
CPT 92227 covers retinal imaging with remote clinical staff review and report. CPT 92228 adds remote physician or qualified health professional interpretation and a unilateral report. Both meet medical necessity criteria when used for diabetic retinopathy or ROP screening. CPT 92229 — the autonomous AI analysis code — is covered for diabetic retinopathy screening only. It is not covered for ROP screening under any circumstances.
This policy does not mention prior authorization requirements directly. That said, if you're billing 92229 in a neonatal context and expecting reimbursement, don't. Aetna has explicitly excluded AI-based autonomous analysis for ROP regardless of documentation.
Aetna Retinopathy Telescreening Exclusions and Non-Covered Indications
This is where the policy does real damage to revenue cycle teams who haven't read it carefully.
Aetna considers AI-based telescreening systems experimental, investigational, and unproven for ROP screening. CPT 92229 is specifically flagged here. If your NICU or neonatal team has been using an AI-based system and billing 92229 for premature infants, those claims are not covered under this policy.
The second exclusion is broader and catches more practices off guard. Aetna will not cover retinopathy telescreening — under any of the three CPT codes — for monitoring disease progression in patients already diagnosed with diabetic retinopathy. This is a common workflow in high-volume diabetes care: screen, diagnose, then use the same system to track the patient over time. That third step is now explicitly non-covered.
The ICD-10 codes tied to this exclusion span the full diabetic retinopathy range across E08, E09, E10, E11, and E13 categories. The policy lists 487 ICD-10-CM codes in total. Most map to diabetic retinopathy. If you're using those diagnosis codes in follow-up visits with an existing retinopathy diagnosis, Aetna won't pay for the telescreening component.
Finally, Aetna excludes telescreening for any retinal condition other than diabetic retinopathy or ROP. Macular degeneration and macular edema are called out by name in the policy. If your team has been using 92228 or 92227 for macular imaging, those claims will deny. This is not a gray area — the policy language is explicit.
Coverage Indications at a Glance
| Indication | Status | Relevant Codes | Notes |
|---|---|---|---|
| Diabetic retinopathy screening (initial/preventive) | Covered | 92227, 92228, 92229, S3000 | Medical necessity criteria must be met; screening use only |
| Retinopathy of prematurity (ROP) screening — non-AI system | Covered | 92227, 92228 | Covered as alternative to ophthalmologist/optometrist screening |
| ROP screening — AI-based autonomous analysis | Not Covered / Experimental | 92229 | AI effectiveness not established for ROP; claim will deny |
| Monitoring disease progression in diagnosed diabetic retinopathy patients | Not Covered | 92227, 92228, 92229 | Telescreening not covered for follow-up monitoring once diagnosis is established |
| Macular degeneration / macular edema screening or evaluation | Not Covered | 92227, 92228, 92229 | Explicitly excluded; not an all-inclusive list of excluded retinal conditions |
| Other retinal conditions (non-DR, non-ROP) | Not Covered | 92227, 92228, 92229 | Insufficient clinical evidence for non-DR, non-ROP indications |
Aetna Retinopathy Telescreening Billing Guidelines and Action Items 2025
| # | Action Item |
|---|---|
| 1 | Stop billing CPT 92229 for ROP immediately. The effective date is December 4, 2025. Any 92229 claim with a diagnosis code tied to retinopathy of prematurity will deny under this policy. Pull your claims from Q4 2025 and flag any that used 92229 in a neonatal setting. |
| 2 | Audit your diabetic retinopathy follow-up workflow. If your practice monitors established DR patients with telescreening and bills 92227 or 92228 for those visits, those claims are non-covered. The covered use is screening — catching DR before it's diagnosed. Check your ICD-10 coding. If the diagnosis code reflects an existing DR finding (E08.31x through E13.x ranges), Aetna won't pay for the telescreening service. |
| 3 | Review all retinal imaging billing where the diagnosis is not DR or ROP. Any claim pairing 92227, 92228, or 92229 with a macular degeneration or macular edema ICD-10 will deny. The same applies to other retinal conditions outside the covered indications. |
| 4 | Separate your charge capture by indication type. Your EHR or charge capture system needs to distinguish between initial DR screening visits and follow-up monitoring visits. These are clinically similar workflows — they are not the same for billing purposes under this policy. |
| 5 | Train your coding team on the screening vs. monitoring distinction. This is the core of the policy. Billing guidelines here hinge on whether the patient has a pre-existing DR diagnosis. A patient presenting for annual diabetic eye screening with no prior DR diagnosis: covered. A patient with documented non-proliferative DR returning for a follow-up telescreening visit: not covered. Your coders need to know the difference before they assign diagnosis codes. |
| 6 | Verify HCPCS S3000 claims separately. S3000 (dilated bilateral diabetic retinal exam) is listed as an other related code in the policy. Its coverage status is not directly addressed in the same covered/not-covered framework as the CPT codes. If you bill S3000, verify its status with your Aetna contract or your billing consultant before the effective date. |
| 7 | Talk to your compliance officer if your practice runs a high volume of post-diagnosis DR monitoring visits. The financial exposure here depends on your patient mix. If you're a high-volume diabetes practice or endocrinology group that screens and then monitors with the same system, this policy change cuts directly into your reimbursement model. Get a compliance review before December 4, 2025. |
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
CPT, HCPCS, and ICD-10 Codes for Retinopathy Telescreening Under CPB 0563
Covered CPT Codes (When Selection Criteria Are Met)
| Code | Type | Description |
|---|---|---|
| 92227 | CPT | Imaging of retina for detection or monitoring of disease; with remote clinical staff review and report |
| 92228 | CPT | Imaging of retina for detection or monitoring of disease; with remote physician or other qualified health care professional interpretation and report, unilateral or bilateral |
| 92229 | CPT | Imaging of retina; point-of-care autonomous analysis and report, unilateral or bilateral — Note: NOT covered for retinopathy of prematurity screening |
Key ICD-10-CM Diagnosis Codes
The full policy includes 487 ICD-10-CM codes. The table below shows the first set of documented codes from the policy. All listed codes map to diabetic retinopathy categories and carry the explicit note that they are not covered for following disease progression in members already diagnosed with diabetic retinopathy.
| Code | Description |
|---|---|
| E08.311 | Diabetes mellitus due to underlying condition with unspecified diabetic retinopathy with macular edema |
| E08.3211 | Diabetes mellitus due to underlying condition with mild nonproliferative diabetic retinopathy with macular edema, right eye |
| E08.3212 | Diabetes mellitus due to underlying condition with mild nonproliferative diabetic retinopathy with macular edema, left eye |
| E08.3213 | Diabetes mellitus due to underlying condition with mild nonproliferative diabetic retinopathy with macular edema, bilateral |
| E08.3214 | Diabetes mellitus due to underlying condition with mild nonproliferative diabetic retinopathy with macular edema, right eye with unspecified macular degeneration |
| E08.3215 | Diabetes mellitus due to underlying condition with mild nonproliferative diabetic retinopathy with macular edema, left eye with unspecified macular degeneration |
| E08.3216 | Diabetes mellitus due to underlying condition with mild nonproliferative diabetic retinopathy with macular edema, bilateral with unspecified macular degeneration |
| E08.3311 | Diabetes mellitus due to underlying condition with moderate nonproliferative diabetic retinopathy with macular edema, right eye |
| E08.3312 | Diabetes mellitus due to underlying condition with moderate nonproliferative diabetic retinopathy with macular edema, left eye |
| E08.3313 | Diabetes mellitus due to underlying condition with moderate nonproliferative diabetic retinopathy with macular edema, bilateral |
The full ICD-10 code list spans E08 through E13 subcategories covering all diabetes types with nonproliferative, proliferative, and unspecified diabetic retinopathy variants. If your practice codes diabetic retinopathy across any of these ranges for telescreening, the non-coverage rule for progression monitoring applies.
Review the complete code list at the full policy on PayerPolicy CPB 0563.
Get the Full Picture for CPT 92227
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.